Lupus Bio - B (02157.HK) announced its interim performance for the six months ending in June of this year, with revenue of 0.133 billion RMB (same below), down 13.2% year-on-year. The loss expanded to 0.192 billion yuan, compared to a loss of 0.142 billion yuan in the same period last year; loss per share was 0.12 yuan. No dividend will be distributed.
《業績》樂普生物－Ｂ(02157.HK)半年虧損擴大至1.92億元人民幣
In terms of performance, Lu Pu Biotechnology - B (02157.HK) expanded its half-year loss to 0.192 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated